Dengue Challenge Trial Shows Preexisting Antibodies Shape Secondary Viral Infection Severity
A phase 1 controlled human challenge trial in 45 healthy adults reveals that preexisting antibodies directly shape viral replication and ...
A phase 1 controlled human challenge trial in 45 healthy adults reveals that preexisting antibodies directly shape viral replication and ...
A phase 1 expansion cohort demonstrated meaningful antitumor responses and manageable safety for liposomal eribulin as first-line chemotherapy in metastatic ...
A phase 1 trial found that a pill of 16 selected beneficial bacteria was safe for stem cell transplant patients ...
In the first-in-human TheraPb phase 1 trial, the alpha-emitting radiopharmaceutical 212Pb-ADVC001 was well tolerated at doses of 60–200 MBq with ...
A first-in-human phase 1 trial at UCI Health is using padeliporfin vascular-targeted photodynamic therapy to destroy pancreatic tumors encasing major ...
A Phase 1 trial presented at ESMO 2026 reports a 40% objective response rate at 130 mg for ISM6331, a ...
Insilico Medicine plans to present first human Phase 1 data for the AI-designed pan-TEAD inhibitor ISM6331 in mesothelioma and other ...
Weill Cornell Medicine researchers have received an $8.2 million NIH grant to advance an experimental on-demand male contraceptive pill, which ...
A phase 1 trial found that intranasal creatine prodrug CBT101 was tolerated and produced exploratory EEG changes consistent with central ...
Kansai Medical University Hospital gave the first worldwide dose of investigational CD25-directed antibody drug conjugate DS1025 in a global Phase ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine